Vazquez, M. Q., James, D., Baseviciene, A., Powell, L., Edwards, K., Coombes, Z., . . . Johnson, A. (2023). Bromodomain inhibitor i-BET858 triggers a unique transcriptional response coupled to enhanced DNA damage, cell cycle arrest and apoptosis in high-grade ovarian carcinoma cells. Clinical Epigenetics, 15(1), . doi:10.1186/s13148-023-01477-x

Vazquez, Marcos Quintela, et al. "Bromodomain Inhibitor I-BET858 Triggers a Unique Transcriptional Response Coupled to Enhanced DNA Damage, Cell Cycle Arrest and Apoptosis in High-grade Ovarian Carcinoma Cells." Clinical Epigenetics 15, no. 1 (2023).

Vazquez, Marcos Quintela, et al. "Bromodomain Inhibitor I-BET858 Triggers a Unique Transcriptional Response Coupled to Enhanced DNA Damage, Cell Cycle Arrest and Apoptosis in High-grade Ovarian Carcinoma Cells." Clinical Epigenetics 15.1 (2023).